Author
Listed:
- Yongqing Liu
(Molecular Targets Program, James Brown Cancer Center, University of Louisville Health Sciences Center
University of Louisville Health Sciences Center
Birth Defects Center, University of Louisville Health Sciences Center)
- Xiaoqin Lu
(University of Louisville Health Sciences Center)
- Li Huang
(University of Louisville Health Sciences Center
College of Agriculture and Biotechnology, Zejiang University)
- Wei Wang
(University of Louisville Health Sciences Center)
- Guomin Jiang
(University of Louisville Health Sciences Center)
- Kevin C. Dean
(University of Louisville Health Sciences Center)
- Brian Clem
(Molecular Targets Program, James Brown Cancer Center, University of Louisville Health Sciences Center)
- Sucheta Telang
(Molecular Targets Program, James Brown Cancer Center, University of Louisville Health Sciences Center)
- Alfred B. Jenson
(Molecular Targets Program, James Brown Cancer Center, University of Louisville Health Sciences Center)
- Miriam Cuatrecasas
(Centro de Diagnóstico Biomédico (CDB) Hospital Clínic, University of Barcelona
Tumor Bank-Biobank, IDIBAPS)
- Jason Chesney
(Molecular Targets Program, James Brown Cancer Center, University of Louisville Health Sciences Center)
- Douglas S. Darling
(Endodontics, and Dental Hygiene, University of Louisville)
- Antonio Postigo
(Molecular Targets Program, James Brown Cancer Center, University of Louisville Health Sciences Center
Group of Transcriptional Regulation of Gene Expression, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)
ICREA)
- Douglas C. Dean
(Molecular Targets Program, James Brown Cancer Center, University of Louisville Health Sciences Center
University of Louisville Health Sciences Center
Birth Defects Center, University of Louisville Health Sciences Center)
Abstract
Ras pathway mutation is frequent in carcinomas where it induces expression of the transcriptional repressor ZEB1. Although ZEB1 is classically linked to epithelial–mesenchymal transition and tumour metastasis, it has an emerging second role in generation of cancer-initiating cells. Here we show that Ras induction of ZEB1 is required for tumour initiation in a lung cancer model, and we link this function to repression Pten, whose loss is critical for emergence of cancer-initiating cells. These two roles for ZEB1 in tumour progression can be distinguished by their requirement for different levels of ZEB1. A lower threshold of ZEB1 is sufficient for cancer initiation, whereas further induction is necessary for tumour metastasis.
Suggested Citation
Yongqing Liu & Xiaoqin Lu & Li Huang & Wei Wang & Guomin Jiang & Kevin C. Dean & Brian Clem & Sucheta Telang & Alfred B. Jenson & Miriam Cuatrecasas & Jason Chesney & Douglas S. Darling & Antonio Post, 2014.
"Different thresholds of ZEB1 are required for Ras-mediated tumour initiation and metastasis,"
Nature Communications, Nature, vol. 5(1), pages 1-10, December.
Handle:
RePEc:nat:natcom:v:5:y:2014:i:1:d:10.1038_ncomms6660
DOI: 10.1038/ncomms6660
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:5:y:2014:i:1:d:10.1038_ncomms6660. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.